When mice bearing ODC1-knockdown tumors were treated with systemic SPD, we observed a partial rescue of our original phenotype, indicating that tumor cell–derived SPD is a significant contributor of GBM progression (Figure 5G). This evidence concerns the gene ODC1 and neoplasm.